双重COX-2/CaV2.2抑制剂的设计和表征具有强烈的止痛活性
Jie Qiu1, Shouwei Tao1, Tian Zhang1
1Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Journal of medicinal chemistry
|January 29, 2026
概括
一种针对循环氧化酶-2 (COX-2) 和N型通道 (CaV2.2) 的新型双重抑制剂显示出强大的疼痛缓解作用. 化合物5d有效降低炎症和神经信号,为慢性疼痛管理提供了一个有前途的多机制方法.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 循环氧化酶-2 (COX-2) 和N型电压通道 (CaV2.2) 是炎症和疼痛信号的关键媒介.
- 针对COX-2和CaV2.2提供了一种潜在的协同策略,可以增强疼痛缓解.
研究的目的:
- 设计和合成基于二甲的新型化合物作为COX-2和CaV的双重抑制剂2.2.2.
- 确定一种化合物,对两个目标具有平衡的效能和选择性.
主要方法:
- 合成了一系列的二甲酸衍生物.
- 结构-活性关系 (SAR) 分析以确定最佳抑制剂.
- 对于COX-2和CaV的体外酶抑制试验2.2.
- 在各种疼痛模型 (炎症性,神经病变性,内脏性) 中进行体内止痛疗效测试.
主要成果:
- 化合物5d成为主要候选物,证明了COX-2 (IC50 = 0.26 ± 0.17 μM) 和CaV2.2 (IC50 = 0.29 ± 0.07 μM) 的平衡抑制.
- 化合物5d在多个临床前疼痛模型中表现出显著的止痛作用.
- 该化合物有效地抑制了炎症反应,并调节了 nociceptive 信号传递.
结论:
- 基于二甲的化合物可以有效地抑制COX-2和CaV2.2.
- 化合物5d代表了一种有前途的多机制止痛剂,用于慢性疼痛.
- 对5d化合物的进一步研究是有必要的,因为它具有治疗潜力.
相关概念视频
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.0K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.0K
The Mantel-Cox Log-Rank Test
1.0K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Group Design
10.4K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.4K


